- Home
- ICCC vs ACFN Comparison
ICCC vs ACFN Comparison
Compare ICCC & ACFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- ACFN
- Stock Information
- Founded
- ICCC 1982
- ACFN 1986
- Country
- ICCC United States
- ACFN United States
- Employees
- ICCC N/A
- ACFN N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- ACFN Military/Government/Technical
- Sector
- ICCC Health Care
- ACFN Consumer Discretionary
- Exchange
- ICCC Nasdaq
- ACFN Nasdaq
- Market Cap
- ICCC 55.5M
- ACFN 63.5M
- IPO Year
- ICCC 1987
- ACFN N/A
- Fundamental
- Price
- ICCC $6.16
- ACFN $25.11
- Analyst Decision
- ICCC
- ACFN
- Analyst Count
- ICCC 0
- ACFN 0
- Target Price
- ICCC N/A
- ACFN N/A
- AVG Volume (30 Days)
- ICCC 19.4K
- ACFN 15.4K
- Earning Date
- ICCC 11-13-2025
- ACFN 11-10-2025
- Dividend Yield
- ICCC N/A
- ACFN N/A
- EPS Growth
- ICCC N/A
- ACFN 1520.82
- EPS
- ICCC 0.20
- ACFN 2.84
- Revenue
- ICCC $28,274,756.00
- ACFN $13,202,000.00
- Revenue This Year
- ICCC N/A
- ACFN N/A
- Revenue Next Year
- ICCC N/A
- ACFN N/A
- P/E Ratio
- ICCC $31.10
- ACFN $8.82
- Revenue Growth
- ICCC 21.75
- ACFN 50.98
- 52 Week Low
- ICCC $3.38
- ACFN $17.22
- 52 Week High
- ICCC $7.60
- ACFN $33.00
- Technical
- Relative Strength Index (RSI)
- ICCC 46.17
- ACFN 45.65
- Support Level
- ICCC $6.06
- ACFN $23.00
- Resistance Level
- ICCC $6.75
- ACFN $26.47
- Average True Range (ATR)
- ICCC 0.36
- ACFN 1.74
- MACD
- ICCC -0.04
- ACFN -0.04
- Stochastic Oscillator
- ICCC 15.31
- ACFN 46.89
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About ACFN Acorn Energy Inc. Common Stock
Acorn Energy Inc is a holding company that focuses on technology-driven solutions for energy infrastructure asset management. It operates through two segments namely, the PG segment and the CP segment. PG segment provides wireless remote monitoring and control systems and services for critical assets as well as Internet of Things applications which account for the majority of the revenue. CP segment is engaged in providing remote monitoring of cathodic protection systems on gas pipelines for gas utilities and pipeline companies.